Open the mobile version, with barcode scanning
Class II Terminated

Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o.

Why: Packaging defect: observed packaging defect, blister packaging inadequately sealed.

Company
The Harvard Drug Group
La Vergne, TN, United States
Reported
Mar 8, 2023
Recall started
Feb 23, 2023
Ended
Apr 30, 2024
Where sold
Distributed Nationwide in the USA
Amount
17,586 cartons
Full product description
Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4
Lots / codes affected
Lot: M04145 Exp. 01/2024

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.